AKT2 Blocking Peptide Cat No: CBP1039 Source: Synthetic Reactivity: H, M, R, C, D Applications: BL Description: The peptide is used to block Anti-AKT2 Antibody (#CPA1039) reactivity.
AKT Blocking Peptide Cat No: CBP1037 Source: Synthetic Reactivity: H, M, R, B, P, S Applications: BL Description: The peptide is used to block Anti-AKT Antibody (#CPA1037) reactivity.
AKT Blocking Peptide Cat No: CBP1036 Source: Synthetic Reactivity: H, M, R, B, C, Z Applications: BL Description: The peptide is used to block Anti-AKT Antibody (#CPA1036) reactivity.
AKT Blocking Peptide Cat No: CBP1035 Source: Synthetic Reactivity: H, M, R, B, C, P, S, Z Applications: BL Description: The peptide is used to block Anti-AKT Antibody (#CPA1035) reactivity.
AKT Blocking Peptide Cat No: CBP1034 Source: Synthetic Reactivity: H, M, R, B, C, D, Z Applications: BL Description: The peptide is used to block Anti-AKT Antibody (#CPA1034) reactivity.
AKT (pY315) Blocking Peptide Cat No: CBP1033 Source: Synthetic Reactivity: H, M, R, B, C, Z Applications: BL Description: The peptide is used to block Anti-AKT (pY315) Antibody (#CPA1033) reactivity.
AKT (pT308) Blocking Peptide Cat No: CBP1032 Source: Synthetic Reactivity: H, M, R, B, C, Z Applications: BL Description: The peptide is used to block Anti-AKT (pT308) Antibody (#CPA1032) reactivity.
AKT (pS473) Blocking Peptide Cat No: CBP1031 Source: Synthetic Reactivity: H, M, R, B, S, Z Applications: BL Description: The peptide is used to block Anti-AKT (pS473) Antibody (#CPA1031) reactivity.
Aggrecan Blocking Peptide Cat No: CBP1030 Source: Synthetic Reactivity: H, M, R, B, D, P, Rb, S Applications: BL Description: The peptide is used to block Anti-Aggrecan Antibody (#CPA1030) reactivity.
GRK2 Blocking Peptide Cat No: CBP1029 Source: Synthetic Reactivity: H, M, R, B, D, P Applications: BL Description: The peptide is used to block Anti-GRK2 Antibody (#CPA1029) reactivity.
GRK2 (pS29) Blocking Peptide Cat No: CBP1028 Source: Synthetic Reactivity: H, M, R, B Applications: BL Description: The peptide is used to block Anti-GRK2 (pS29) Antibody (#CPA1028) reactivity.
